Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between these …

Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …

The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …

Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …

BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes
significant morbidity and mortality. The aim of these clinical standards is to provide guidance …

… chelonae-M. abscessus group taxonomy has undergone several updates due to the …
proposed species that are closely related to M. abscessus and M. chelonae, and consequently they …

The World Health Organization (WHO) recommends that countries implement pharmacovigilance
and collect information on active drug safety monitoring (aDSM) and management of …

Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease.
With growing drug resistance the epidemic remains and will require significant attention and …

… Nodular bronchiectatic features were more prevalent among patients with M. abscessus
subsp… Parenteral amikacin was more frequently prescribed to patients with M. abscessus subsp. …

BACKGROUND: Tuberculosis (TB) preventive therapy (TPT) decreases the risk of developing
TB disease and its associated morbidity and mortality. The aim of these clinical standards …